Please login to the form below

Not currently logged in
Email:
Password:

DH invites proposals for genetics funding

DH and the Wellcome Trust are inviting proposals from organisations and research groups for funding from the Health Innovation Challenge Fund

The Department of Health (DH) and the Wellcome Trust are inviting proposals from organisations and research groups seeking to draw on funding from the Health Innovation Challenge Fund. 'Advancing Genetic Discoveries into Clinical Practice' is the first area of expertise to be offered funding, with up to £20m.

Medical genetics is the first of a number of areas that the Health Innovation Challenge Fund will offer funding for. The aim of the cash injection is to help capitalise on the wealth of information created by human genome analysis and to bring the emerging insights to clinical application. The Health Innovation Challenge Fund can support initiatives for up to five years and has a total of up to £100m available, contributed in equal measure by the DH and the Wellcome Trust.

The purpose of the Health Innovation Challenge Fund is to facilitate high-quality technological developments that can deliver economic and patient health benefits and build on the UK's excellence in science. The initiative will stimulate the delivery of technologies, products and interventions having clinical applicability within the NHS.

20th July 2009

From: Healthcare

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

Beyond the event
...
Anthill Agency and Actando partnership to Transform Pharma's Digital Skills
Anthill Agency, a leading life sciences digital agency, today announced the launch of the Anthill Academy™ and partnership with Actando's PharmAcademy....
Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...

Infographics